Gut microbe metabolite TMA improves blood sugar by shutting down a key inflammatory switch
A microbial metabolite long linked to cardiovascular risk emerges as a surprising ally against metabolic inflammation, revealing how…
Do they affect gut health? – The Irish Times
Walk into a supermarket, and much of what you see – breakfast cereals, frozen meals, processed meats –…
Hotter days and nights are already stealing sleep across the U.S.
Using more than 12 million nights of wearable sleep data, researchers show that warmer days and nights already…
Health insurer prescription costs rise 20%, GLP-1s cited as cause
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Thinness obsession prompts diet drug misuse in South Korea
SEOUL (The Korea Herald/ANN): A wave of demand for weight-loss medication is sweeping South Korea, a country that…
New C-COMPASS software opens spatial proteomics and lipidomics to non-coders
A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of…
Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks – National
Negotiations that could have led to coverage of weight-loss drug Wegovy under Canadian public health plans are not…
WHO calls obesity a chronic disease, endorses GLP-1 drugs with behavioural therapy in fresh guidelines
The World Health Organization has come out with the first ever guidelines on the global use of Glucagon-Like…
WHO releases first guideline on the use of GLP-1 therapies for treating obesity
To address the growing global health challenge of obesity, which affects more than 1Â billion people, the World Health…
Early-life nutrition | National Institutes of Health (NIH)
Research in Context  November 25, 2025 Exposures in the womb can affect lifelong health Nutrition matters, and what young,…
Lilly cuts price for obesity drug Zepbound
Trump announces lower prices coming for GLP-1 drugs Zepbound, Wegovy President Donald Trump announces discounted pricing for Zepbound…
Ozempic-style drugs should be available to all, not just the rich, says WHO – POLITICO
The WHO wants pharma companies to consider tiered pricing (lower prices in lower-income countries) and voluntary licensing of…